RxDoctor Payments Data

Sibonisiwe Johnson, NP

Nurse Practitioner · Moreno Valley, CANPI 1255872719

Payments from drug & device makers

What this record shows

This record is dominated by other: $3,328 of the $4,163 with a category attached, or 79.9%. International Rehabilitative Sciences, Inc accounts for 80.3% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $3,555, more than ten times the $290 reported in 2021. Among nurse practitioner clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,163in general payments, 2019–2025

Across 42 payments — averaging $99.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • International Rehabilitative Sciences, Inc$3K
  • AstraZeneca$202
  • Akebia Therapeutics Inc$143
  • Smith+Nephew$135
  • Paratek Pharmaceuticals, Inc.$109
  • Amgen$80
  • plus $151 from 7 others

What the payments were for

  • Food & beverage$83520%
  • Other$3,32880%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,163 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California →

Medicare billing

Part B allowed, 2024
$20,405
Medicare patients
101
Services billed
348

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth15$1,237
Albuterol Sulfate HfaAlbuterol Sulfate21$480
Doxycycline Monohydrate12$301
Lidocaine Hcl ViscousLidocaine Hcl32$213
Cephalexin36$177
Metronidazole13$176
Azithromycin35$149
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav21$138
Ciprofloxacin Hcl21$83
Fluconazole26$64
Prednisone17$49
Baclofen22$43

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Moreno Valley

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →